Article
P53 and induction of apoptosis as a target for anticancer therapy.
Leukemia - 1 Jul 1996
Neubauer A, Thiede C, Huhn D, Wittig B
Abstract excerpt
p53 is the most frequently mutated gone in human cancer cells. Its wild-type gone encodes for a protein with pivotal functions: (i) interaction with key players in the cell cycle leading to cell cycle arrest; (ii) induction of programmed call death, or apoptosis. P53 may be seen as another member of the family of proteins involved in resistance to anticancer therapy, since mutations/deletions involving the p53...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
